A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Translational Medicine

Topics

Medicine

Pathology

Internal Medicine

Surgery

Molecular Biology

Show all topics

DOI

10.1186/1479-5876-11-143

License

CC-BY

Other Formats

PDF